Secondary malignant neoplasm of bilateral ovaries
ICD-10 C79.63 is a billable code used to indicate a diagnosis of secondary malignant neoplasm of bilateral ovaries.
C79.63 refers to the presence of metastatic cancer in both ovaries, originating from a primary malignancy located elsewhere in the body. This condition is characterized by the spread of cancerous cells to the ovaries, which can occur from various primary sites, including breast, colon, or gastrointestinal cancers. The diagnosis of secondary malignant neoplasm of the ovaries often indicates advanced disease and may present with symptoms such as abdominal pain, bloating, or changes in menstrual patterns. Staging of the disease is crucial, as it helps determine the extent of metastasis and guides treatment options. In many cases, the primary tumor may remain unknown at the time of diagnosis, necessitating thorough investigation to identify the source. Palliative care considerations are essential for managing symptoms and improving the quality of life for patients, as treatment may focus on alleviating discomfort rather than curative intent.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with abdominal symptoms and known history of malignancy.
Ensure clear documentation of the primary cancer site and staging.
Gynecological examinations, imaging results, and surgical reports are essential.
Patients with unexplained ovarian masses and a history of cancer.
Differentiating between primary ovarian cancer and metastatic disease is crucial.
Used when a biopsy of the ovarian mass is performed.
Pathology report must indicate the presence of metastatic cells.
Oncologists and pathologists must collaborate for accurate diagnosis.
Coding C79.63 accurately reflects the presence of metastatic disease in the ovaries, which is crucial for treatment planning and understanding the patient's prognosis.
